Pediatric KIDney Stone (PKIDS) Care Improvement Network

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Recruiting
CT.gov ID
NCT04285658
Collaborator
Patient-Centered Outcomes Research Institute (Other)
1,290
31
45
41.6
0.9

Study Details

Study Description

Brief Summary

The goals of this study are to improve the ability of pediatric patients and their caregivers to select surgical treatment options for kidney stones and to enable urologists to use techniques that result in the best outcomes for these surgeries.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ureteroscopy
  • Procedure: Percutaneous Nephrolithotomy
  • Procedure: Shock Wave Lithotripsy

Detailed Description

The rapid increase in the incidence of kidney stones among youth has resulted in a large population of patients who require surgery to removes stones but for whom little evidence exists to guide clinical care. Proper selection of surgical treatment options, which is directed by patient-specific factors and individual treatment goals, is the greatest determinant of successful outcomes.

This is a prospective cohort study. Investigators seek to compare stone clearance, re-treatment, and unplanned healthcare encounters for ureteroscopy, shockwave lithotripsy, and percutaneous nephrolithotomy.

Additionally, Investigators also seek to compare patients' experiences after ureteroscopy, shockwave lithotripsy, and percutaneous nephrolithotomy.

Setting/Participants:

This study will be conducted by the Pediatric KIDney Stone (PKIDS) Care Improvement Network, which includes 23 pediatric healthcare systems (25 sites) in the United States.

Patient participants include patients aged 8 to 21 years who undergo a surgical intervention for kidney stones as part of their clinical care. The surgical interventions include ureteroscopy, shockwave lithotripsy, and percutaneous nephrolithotomy, all of which would be performed as part of routine clinical care.

Study Interventions and Measures:

Stone clearance will be assessed with ultrasound (obtained as part of clinical care) 6 weeks after surgery, which is the standard of care at all PKIDS sites. Re-treatment and unplanned healthcare encounters will be assessed within the first 3 months after surgery. Patients' experiences will be measured through questionnaires administered pre-operatively and within 3 months after surgery.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1290 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pediatric KIDney Stone (PKIDS) Care Improvement Network
Actual Study Start Date :
Apr 2, 2020
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Ureteroscopy

Procedure: Ureteroscopy
An outpatient endoscopic surgery that accesses the ureters and kidneys per the urethra to fragment and remove the stones. Many patients who undergo ureteroscopy (URS), Shockwave lithotripsy (SWL), or percutaneous nephrolithotomy (PCNL) also have temporary tubes placed after the surgery to facilitate drainage, either internally (a stent) or externally (a nephrostomy tube).
Other Names:
  • URS
  • Percutaneous Nephrolithotomy

    Procedure: Percutaneous Nephrolithotomy
    A minimally invasive surgery in which a ~1cm flank incision is made, and a scope is passed through a tubular sheath into the kidney to fragment and remove the stone. There is typically a 1- to 2-day hospital stay. Many patients who undergo URS, SWL, or PCNL also have temporary tubes placed after the surgery to facilitate drainage, either internally (a stent) or externally (a nephrostomy tube).
    Other Names:
  • PCNL
  • Shock Wave Lithotripsy

    Procedure: Shock Wave Lithotripsy
    A non-invasive outpatient procedure that targets stones in the kidney or ureter with x-ray or ultrasound and uses shockwaves generated outside the body to fragment them; the fragments pass down the ureter and the patient expels them in the urine. Many patients who undergo URS, SWL, or PCNL also have temporary tubes placed after the surgery to facilitate drainage, either internally (a stent) or externally (a nephrostomy tube).
    Other Names:
  • SWL
  • Outcome Measures

    Primary Outcome Measures

    1. Stone clearance [6 weeks post-op +/- 2 weeks]

      Presence or absence of kidney stones will be assessed via post-operative clinically-indicated renal bladder ultrasound.

    Secondary Outcome Measures

    1. Patient-Reported Outcomes [Immediate impact (within 7 days) and delayed impact (up to 90 days) after surgery]

      Patients' experiences before and after URS, SWL, and PCNL will be measured. Investigators will assess the immediate and delayed impact of surgery on patient-reported outcomes (PROs) selected by PKIDS patient partners. The patient reported outcomes (PROs) include the Patient-Reported Outcomes Measurement Information System (PROMIS), other questionnaires commonly used in studying the impact of kidney stone disease on health states, and urinary tract symptoms.

    2. Patients' Experiences [Immediate impact (within 7 days) and delayed impact (up to 90 days) after surgery]

      Investigators will examine Heterogeneity of Treatment Effect (HTE) by age and sex and identify modifiable surgical techniques that impact patient experiences for each surgery.

    3. Patients' Experiences [Up to 90 days after surgery]

      Investigators will also determine unplanned hospitalizations, emergency department (ED) visits, and repeat surgeries for the 3 months following each procedure to examine impact on patients' experiences.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 21 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Males or females, 8-21 years of age, undergoing planned URS, SWL, or PCNL for the removal of at least one kidney and/or ureteral stone.

    2. Parental/guardian or participant (if ≥ 18 years old) permission (informed consent), and if appropriate, child assent

    2a. Individuals who are not able to provide consent/assent (whether ≥18 or < 18 years) and/or not willing or able to complete questionnaires are eligible for participation for the stone clearance assessment and Electronic Health Record (EHR) surveillance if the legal guardian consents for study participation.

    2b. Individuals for whom native-language questionnaires are not available can also participate in stone clearance assessment and EHR surveillance.

    Exclusion Criteria:
    1. Patients for whom conducting informed consent and baseline study procedures would confer additional risk (e.g. obstructing ureteral stone with fever requiring emergency surgery) and delay necessary immediate clinical care.

    2. Parent/guardians or patients, who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's of Alabama Birmingham Alabama United States 35233
    2 Children's Hospital Los Angeles Los Angeles California United States 90027
    3 UCLA Mattel Children's Hospital Los Angeles California United States 90095
    4 Children's Hospital Colorado Aurora Colorado United States 80045
    5 Nemours A. I. duPont Hospital for Children Wilmington Delaware United States 19803
    6 Children's National Health System Washington District of Columbia United States 20010
    7 University of Florida Health Shands Children's Hospital Gainesville Florida United States 32608
    8 Nemours Children's Specialty Care Jacksonville Florida United States 32207
    9 AdventHealth Orlando Orlando Florida United States 32803
    10 Nemours Children's Hospital Orlando Florida United States 32827
    11 Children's Hospital of Atlanta Atlanta Georgia United States 30322
    12 Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois United States 60611
    13 Riley Hospital for Children Indianapolis Indiana United States 46204
    14 University of Kentucky Lexington Kentucky United States 40506
    15 Boston Children's Hospital Boston Massachusetts United States 02115
    16 University of Michigan Ann Arbor Michigan United States 48109
    17 St. Louis Children's Hospital Saint Louis Missouri United States 63110
    18 Cohen Children's Medical Center New York New York United States 11040
    19 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229
    20 Nationwide Children's Hospital Columbus Ohio United States 43205
    21 University of Oklahoma Health Sciences Center Oklahoma City Oklahoma United States 73104
    22 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
    23 University of Pennsylvania Philadelphia Pennsylvania United States 19104
    24 Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville Tennessee United States 37232
    25 Children's Medical Center of Dallas Dallas Texas United States 75235
    26 Texas Children's Hospital Houston Texas United States 77030
    27 Primary Children's Hospital Salt Lake City Utah United States 84113
    28 Children's Hospital of Richmond at VCU Richmond Virginia United States 23219
    29 Seattle Children's Hospital Seattle Washington United States 98105
    30 Children's Wisconsin Milwaukee Wisconsin United States 53226
    31 The Hospital for Sick Children Toronto Ontario Canada M5G 1X8

    Sponsors and Collaborators

    • Children's Hospital of Philadelphia
    • Patient-Centered Outcomes Research Institute

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Children's Hospital of Philadelphia
    ClinicalTrials.gov Identifier:
    NCT04285658
    Other Study ID Numbers:
    • 19-016832
    • CER-2018C3-14778
    First Posted:
    Feb 26, 2020
    Last Update Posted:
    Aug 16, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Children's Hospital of Philadelphia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 16, 2022